- Home
- CURX vs INM Comparison
CURX vs INM Comparison
Compare CURX & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURX | INM |
|---|---|---|
| Founded | 2018 | 1981 |
| Country | United States | Canada |
| Employees | 6 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 8.8M |
| IPO Year | 2024 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CURX | INM |
|---|---|---|
| Price | $6.21 | $14.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.2K | ★ 64.4K |
| Earning Date | 09-09-2025 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.68 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $0.21 | $0.58 |
| 52 Week High | $13.33 | $2.33 |
Technical Indicators
Market Signals| Indicator | CURX | INM |
|---|---|---|
| Relative Strength Index (RSI) | 66.52 | 99.23 |
| Support Level | $4.02 | $1.00 |
| Resistance Level | $7.00 | N/A |
| Average True Range (ATR) | 0.43 | 0.50 |
| MACD | 0.12 | 1.24 |
| Stochastic Oscillator | 100.00 | 84.72 |
Price Performance
Historical ComparisonAbout CURX Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.